Plasma Cell Dyscrasias in India-2017 Updates

Abstract

Rapid advances are being made in the field of plasma cell dyscrasias. Many abstracts pertaining to the laboratory aspects, clinical features, treatment modalities and outcome of plasma cell dyscrasias were presented at Hematocon 2017. All the total of 24 abstracts pertaining to plasma cell dyscrasias presented at the Hematocon 2017 were reviewed. Out of them 10 were original research and 14 were case reports/short case series. The key findings of original research studies conducted in India are being summarized. Exciting research in the field of plasma cell dyscrasias is being carried out by various centers in the country. Data presented on various aspects of research in plasma cell disorders is encouraging. Multicentric research in the field plasma cell dyscrasias should be encouraged to highlight the various aspects of disease biology and challenges in management unique to our country.

Cost analysis of implementing mHealth intervention for maternal, newborn & child health care through community health workers: assessment of ReMIND program in Uttar Pradesh, India

“…In light of this it is also important to understand that such mHealth application for RMNCH would thus be more useful in weaker states where the reasons for poor coverage are linked more with the demand for service. For example, the Coverage Evaluation Survey reported that poorer states such as Bihar and Uttar Pradesh have low rates of RMNCH service utilization, a large portion of which is explained by lack of awareness and knowledge about the importance of services [ 36 ]. The findings from our impact assessment study suggested an increase in knowledge and thereby utilization of MNCH services after introduction of ReMiND program [ 14 ].…”

Myeloma at Cross Roads in India

“…Despite the improvements in the varied aspects of the myeloma management, the major challenge we face is the heterogeneity of care provided by the physicians in India [8,9]. We require nation specific consensus guidelines which take into consideration the local issues, heterogeneity of the resources and biology of the Indian patients.…”